Cannabis stocks are gaining attention from investors, with some companies in the sector seeing significant increases in the past week. The list of cannabis companies shows diverse year-to-date returns, with some trading down and others seeing gains. Incannex Healthcare (IXHL) is one notable decliner that has benefited from President Trump’s executive order reclassifying marijuana. The company is up 22% in the past month and 86% in the past six months. Incannex focuses on medicinal cannabis medicines and psychedelic therapies, with potential for growth in the U.S. market.

Incannex’s fundamentals reflect its early-stage status, making it challenging to evaluate based on traditional metrics. Despite a recent stock price boost from Trump’s announcement, IXHL is still down about 80% year-to-date. Analysts have not yet covered the company, leaving investors to rely on narrative and clinical trial updates. With ongoing research and potential FDA approvals, Incannex’s focus on international markets and small market capitalization make it a speculative investment opportunity.

Read more at Barchart: This Cannabis Stock Got Destroyed in 2025. Can Trump Make 2026 a Different Story?